Press "Enter" to skip to content

New patent for Azurity drug QBRELIS

0
Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug QBRELIS

Annual Drug Patent Expirations for QBRELIS
Annual Drug Patent Expirations for QBRELIS

Qbrelis is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.

Drug patent litigation for QBRELIS.

This drug has seven patent family members in seven countries.

The generic ingredient in QBRELIS is lisinopril. One supplier is listed for this compound. Additional details are available on the lisinopril profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug QBRELIS
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions